Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Venous Thromboembolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00329628
What this trial is testing

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Who this might be right for
Venous Thromboembolism
Bayer 4,541
Large-scale testing (Phase 3)Study completedNCT03055026
What this trial is testing

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

Who this might be right for
Prevention of Venous Thromboembolism
Fadoi Foundation, Italy 582
Testing effectiveness (Phase 2)Study completedNCT04031859
What this trial is testing

Risk Stratification Procedure for Thromboembolism Prophylaxis

Who this might be right for
Total Knee Replacement Surgeries
Ministry of Health, Saudi Arabia 242
Not applicableActive Not RecruitingNCT05396157
What this trial is testing

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

Who this might be right for
Thrombosis, VenousBleeding HemorrhageVenous Thromboembolic Disease+2 more
Mount Sinai Hospital, Canada 813
Not applicableStudy completedNCT01947959
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 665,533
Not applicableStudy completedNCT01958203
What this trial is testing

Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.

Who this might be right for
Venous Thromboembolism
Ministry of Health, United Arab Emirates 386
Not applicableStudy completedNCT01444586
What this trial is testing

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

Who this might be right for
Arthroplasty, Replacement, HipArthroplasty, Replacement, Knee
Bayer 2,293
Not applicableUnknownNCT02411097
What this trial is testing

Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism

Who this might be right for
Gonarthrosis
General Hospital of Ningxia Medical University 120
Early research (Phase 1)Study completedNCT02438098
What this trial is testing

Rivaroxaban in Bariatric Surgery

Who this might be right for
Prophylaxis of Venous Thromboembolism
Insel Gruppe AG, University Hospital Bern 13
Large-scale testing (Phase 3)Study completedNCT01181141
What this trial is testing

Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 92
Large-scale testing (Phase 3)Study completedNCT00451412
What this trial is testing

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

Who this might be right for
Thromboembolism
Novartis 3,254
Large-scale testing (Phase 3)Study completedNCT01274637
What this trial is testing

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Who this might be right for
Venous ThromboembolismPostpartum
Ottawa Hospital Research Institute 62
Testing effectiveness (Phase 2)Study completedNCT00398905
What this trial is testing

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 726
Post-approval studies (Phase 4)UnknownNCT02342444
What this trial is testing

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Who this might be right for
TraumaSurgeryDeep Vein Thrombosis (DVT)+1 more
Oregon Health and Science University 606
Large-scale testing (Phase 3)Study completedNCT02369653
What this trial is testing

The Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Who this might be right for
LymphomaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb 512
Post-approval studies (Phase 4)Study completedNCT02958969
What this trial is testing

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Who this might be right for
Venous ThromboembolismMultiple Myeloma
Gregory Piazza 50
Not applicableStudy completedNCT00604370
What this trial is testing

Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge

Who this might be right for
Venous Thromboembolism
Brigham and Women's Hospital 2,500
Not applicableUnknownNCT06196918
What this trial is testing

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Who this might be right for
Glioma, Malignant
Nanfang Hospital, Southern Medical University 320
Not applicableStudy completedNCT06243510
What this trial is testing

Comparison of Apixaban Versus Enoxaparin

Who this might be right for
Bladder Cancer
Abramson Cancer Center at Penn Medicine 126
Large-scale testing (Phase 3)Study completedNCT01028950
What this trial is testing

YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 52
Next Page